Le Lézard
Classified in: Health
Subjects: MAV, LBR, AVO

/R E P E A T -- Media Advisory - OPSEU/SEFPO, NUPGE, and BloodWatch Call for Canadian Blood Services CEO to Resign/

Protest to be held in Ottawa on December 1

OTTAWA, ON, Nov. 30, 2022 /CNW/ - The Ontario Public Service Employees Union (OPSEU/SEFPO), the National Union for Public and General Employees (NUPGE), and BloodWatch.org will protest at Canadian Blood Services' head office in Ottawa on December 1. CBS has signed an undisclosed agreement with Grifols, a private multi-national pharmaceutical manufacturer, allowing Grifols to operate a paid plasma collection scheme across the country, including Ontario.

This is the first time that donors will be paid to donate plasma in Ontario. A paid plasma scheme goes against recommendations from the Krever Commission and would negatively affect voluntary collection efforts. The agreement would allow CBS to exploit a loophole in the Voluntary Blood Donations Act in Ontario and BC, give Grifols a monopoly on plasma collection, and essentially create a two-tiered system for plasma collection in Canada.

OPSEU/SEFPO and its allies are calling for the CBS CEO and board chair to resign, for this agreement to be immediately revoked, and for CBS to properly invest in the current plasma collection infrastructure.

Leaders from across Canada will make formal statements and be available to speak to the media (subject to change):


Thursday, December 1, 2022


8:00 a.m.


CBS Headquarters ? 1800 Alta Vista Dr., Ottawa, K1G 4J5

SOURCE Ontario Public Service Employees Union (OPSEU/SEFPO)

These press releases may also interest you

at 21:58
Today's commitment by the federal government to significantly increase health transfers to provincial and territorial governments is an important step to stabilize and transform our health care systems. The emphasis being placed on primary care,...

at 21:15
The Burn Care Market by Therapy, Type, and Geography - Forecast and Analysis - 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 5.27% and register an incremental growth of USD 843.34 million...

at 21:05
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of its previously announced underwritten public offering of...

at 20:54
Aetna Better Health of West Virginia, a CVS Health® company , has been selected by the West Virginia Department of Health and Human Resources to continue serving Mountain Health Promise members under a new Medicaid managed care contract....

at 20:49
Intellipharmaceutics International Inc. ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage...

at 20:28
CTI BioPharma Corp. today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity awards to three new employees as equity inducement awards outside of the Company's Amended and Restated 2017...

News published on 1 december 2022 at 06:00 and distributed by: